BioTelemetry, CardioNet To Pay $44.8M To Settle FCA Case

By Gina Kim (December 20, 2022, 10:32 PM EST) -- Medical device manufacturer BioTelemetry and its subsidiary CardioNet have agreed to pay $44.8 million to resolve whistleblower claims accusing them of submitting fraudulent claims to federal health care programs for heart monitoring tests and related services performed outside the U.S. and by unqualified offshore technicians, the U.S. Department of Justice announced Tuesday....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!